Egetis Therapeutics
5.37 SEK
+0.19 %
Less than 1K followers
EGTX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
+0.19 %
+8.27 %
+0.56 %
+4.27 %
+7.94 %
+31.94 %
+4.27 %
-6.80 %
-61.19 %
Egetis Therapeutics is a pharmaceutical company focused on developing innovative treatments for rare diseases. The company researches new therapies that can improve patient outcomes and quality of life. The business has a global presence and serves customers worldwide. Egetis Therapeutics was founded in 2006 and is headquartered in Stockholm, Sweden.
Read moreMarket cap
2.28B SEK
Turnover
2.15M SEK
Revenue
62.4M
EBIT %
-544.71 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
29/4
2026
Interim report Q1'26
6/5
2026
General meeting '26
21/8
2026
Interim report Q2'26
All
Webcasts
Press releases
3rd party
ShowingAll content types
NOTICE OF ANNUAL GENERAL MEETING IN EGETIS THERAPEUTICS AB (PUBL)
Egetis erhåller Notice of Allowance avseende MCT8-brist sammansättningspatent i USA
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
